Diego A. Gianolio
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- DNA and Nucleic Acid Chemistry 5
- Glycosylation and Glycoproteins Research 4
- Advanced biosensing and bioanalysis techniques 3
- Hematology 11
- Acute Myeloid Leukemia Research 10
- Co-authors
- Larry W. McLaughlin (4 shared papers)Christian Récher (9 shared papers)Rodrigo T. Calado (9 shared papers)Jianxiang Wang (9 shared papers)Pau Montesinos (8 shared papers)Su‐Peng Yeh (7 shared papers)Andre C. Schuh (8 shared papers)Stéphane de Botton (9 shared papers)
- Journals
- Bioconjugate Chemistry (5 papers)Blood (4 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of the American Chemical Society (2 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Diego A. Gianolio
30 papers receiving 858 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 254
- Oncology 268
- Radiology, Nuclear Medicine and Imaging 211
- Genetics 84
- Molecular Biology 487
Countries citing papers authored by Diego A. Gianolio
This map shows the geographic impact of Diego A. Gianolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego A. Gianolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego A. Gianolio more than expected).
Fields of papers citing papers by Diego A. Gianolio
This network shows the impact of papers produced by Diego A. Gianolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego A. Gianolio. The network helps show where Diego A. Gianolio may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego A. Gianolio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia Hit paper breakdown → | 2022 | 295 |
| 2 | 2014 | 177 | |
| 3 | 2000 | 49 | |
| 4 | 2000 | 48 | |
| 5 | 2020 | 38 | |
| 6 | 2018 | 35 | |
| 7 | 2015 | 34 | |
| 8 | 2012 | 28 | |
| 9 | 2000 | 26 | |
| 10 | 2005 | 17 | |
| 11 | 2000 | 15 | |
| 12 | 2019 | 14 | |
| 13 | 1999 | 13 | |
| 14 | 2013 | 13 | |
| 15 | 2023 | 12 | |
| 16 | 2018 | 11 | |
| 17 | 2008 | 11 | |
| 18 | 2013 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 1999 | 8 |
About Diego A. Gianolio
Diego A. Gianolio is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 889 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers), DNA and Nucleic Acid Chemistry (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Glycosylation and Glycoproteins Research (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Hematology (254 citations), Oncology (268 citations), Radiology, Nuclear Medicine and Imaging (211 citations), Genetics (84 citations) and Molecular Biology (487 citations). Diego A. Gianolio has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Larry W. McLaughlin, Christian Récher, Rodrigo T. Calado, Jianxiang Wang, Pau Montesinos, Su‐Peng Yeh, Andre C. Schuh, Stéphane de Botton, Scott R. Daigle and Ewa Zarzycka. Their work appears in journals such as Bioconjugate Chemistry, Blood, Journal of Clinical Oncology, Molecular Cancer Therapeutics and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.